Israeli company has FDA approval to begin marketing the NeuGuide minimally invasive surgical system
ISRAEL21c , Bio and Archives--January 24, 2018
Health and Medicine | Comments | Reader Friendly | Subscribe | Email Us
Amid mounting calls across the world to ban the controversial use of transvaginal mesh to treat pelvic organ prolapse (POP), Israeli company POP Medical Solutions is introducing NeuGuide, an FDA-cleared minimally invasive repair system uniquely requiring neither dissection nor mesh.
POP is a common but painful and debilitating condition in which pelvic organs (uterus, vagina, bladder or rectum) sag or drop. Up to half of all women experience POP in their lifetime – especially as they age – making this a $1 billion market. The incidence of POP is expected to rise with increasing life expectancy and obesity.View Comments
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.